The Ministry of Health has announced stringent new regulatory measures concerning the sale of Sildenafil, commonly known as the “Blue Pill” or Viagra, in a direct response to growing public health concerns highlighted by a recent Citizen TV documentary.
These new directives aim to curb the widespread availability of the drug without proper medical oversight.
In a statement issued on Monday, December 22, Health Principal Secretary Mary Muthoni unequivocally declared that Sildenafil is now strictly a prescription-only medication and its sale over the counter is prohibited.
“Sildenafil is strictly prescription-only and must not be sold over the counter,” Muthoni emphasized, underscoring the gravity of the situation. This move comes as a critical step to protect citizens from the inherent dangers associated with unsupervised use of the drug.
Sildenafil is primarily prescribed for the treatment of erectile dysfunction in men and pulmonary arterial hypertension. While effective for these conditions, its use without a doctor’s consultation can lead to serious health complications, including cardiovascular events, vision problems, and dangerous interactions with other medications.
Experts at the Kenya Medical Association have long advocated for stricter controls, noting the potential for misuse and abuse when such potent drugs are easily accessible.
The Ministry’s decision reflects a commitment to public safety and responsible pharmaceutical practices. Pharmacies and healthcare providers are now mandated to adhere strictly to these new regulations, ensuring that Sildenafil is dispensed only upon presentation of a valid prescription from a qualified medical professional.
This regulatory overhaul is expected to significantly reduce the risks associated with the illicit and unsupervised consumption of the “Blue Pill” across the nation.
